NEW YORK (GenomeWeb) – Response Genetics has filed a shelf registration with the US Securities and Exchange Commission to offer up to $20 million in securities from time to time.

Securities that may be offered include Response's common stock, preferred stock, and warrants, the company said in its SEC document. Proceeds from any offering will go toward general corporate purposes, such as the funding of its operations, working capital, R&D efforts, capital expenditures, and strategic investments.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.